Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Minerva Neuroscie (NQ: NERV )

6.900 -0.170 (-2.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,704
Open 7.000
Bid (Size) 6.400 (2)
Ask (Size) 8.000 (1)
Prev. Close 7.070
Today's Range 6.510 - 7.200
52wk Range 1.260 - 14.70
Shares Outstanding 6,993,406
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga

Performance

YTD
+356.95%
+356.95%
1 Month
-15.85%
-15.85%
3 Month
-24.51%
-24.51%
6 Month
+331.25%
+331.25%
1 Year
-27.52%
-27.52%

More News

Read More
Top 5 Health Care Stocks That May Collapse This Quarter
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Via Benzinga
Minerva Neurosciences Inc. (NASDAQ: NERV) Near the Top of Equities by Percentage Gain on 6/28
Via Investor Brand Network
Earnings Preview For Minerva Neurosciences
Via Benzinga
Minerva Neurosciences Inc. (NASDAQ: NERV) Leading the Way in Monday Trading Based on Percentage Gain
Via Investor Brand Network
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Nasdaq Moves Higher; US Crude Stocks Drop More than Projected
Via Benzinga
Why Minerva Neurosciences Stock Is Shooting Higher Today
Via Benzinga
Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Dow Drops 100 Points; General Mills Posts Downbeat Sales
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023
From Minerva Neurosciences, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
From Minerva Neurosciences, Inc
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.